Galectin Therapeutics, Inc.

Galectin Therapeutics, Inc.

Sector: In Vitro And In Vivo Diagnostic Substances Region: GA, United States

: | Nasdaq: GALTW | Nasdaq: GALTU | Nasdaq: GALT

Similar to: Bio-Techne, Vitrolife AB, Chembio Diagnostics, Inc.

Galectin Therapeutics, Inc. is a development stage company, which is engaged in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic function and its focus is on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. The company was founded by James C. Czirr and Anatole A. Kltyosov on July 10, 2000 and is headquartered in Norcross, GA.

× We're Sorry! We do not have an investor kit available for this company. Tell us you want one!

News & Analysis

You may also be interested in: